Bendahl PO - Search Results

1

Prognostic impact of circulating tumor cell apoptosis and clusters in serial blood samples from patients with metastatic breast cancer in a prospective observational cohort.

Jansson S, Bendahl PO, Larsson AM, Aaltonen KE, Rydén L. Jansson S, et al. Among authors: bendahl po. BMC Cancer. 2016 Jul 8;16:433. doi: 10.1186/s12885-016-2406-y. BMC Cancer. 2016. PMID: 27390845 Free PMC article.

2

Recurrence-free survival in breast cancer improved by adjuvant tamoxifen--especially for progesterone receptor positive tumors with a high proliferation.

Fernö M, Baldetorp B, Bendahl PO, Borg A, Ewers SB, Olsson H, Rydén S, Sigurdsson H, Killander D. Fernö M, et al. Among authors: bendahl po. Breast Cancer Res Treat. 1995;36(1):23-34. doi: 10.1007/BF00690181. Breast Cancer Res Treat. 1995. PMID: 7579503 Clinical Trial.

3

Urokinase plasminogen activator, a strong independent prognostic factor in breast cancer, analysed in steroid receptor cytosols with a luminometric immunoassay.

Fernö M, Bendahl PO, Borg A, Brundell J, Hirschberg L, Olsson H, Killander D. Fernö M, et al. Among authors: bendahl po. Eur J Cancer. 1996 May;32A(5):793-801. doi: 10.1016/0959-8049(95)00652-4. Eur J Cancer. 1996. PMID: 9081356 Clinical Trial.

4

Proliferative index obtained by DNA image cytometry. Does it add prognostic information in Auer IV breast cancer?

Baldetorp B, Fernö M, Bendahl PO, Fallenius G, Idvall I, Akerman M, Killander D. Baldetorp B, et al. Among authors: bendahl po. Anal Quant Cytol Histol. 1998 Apr;20(2):144-52. Anal Quant Cytol Histol. 1998. PMID: 9569972

5

Steroid receptors in hereditary breast carcinomas associated with BRCA1 or BRCA2 mutations or unknown susceptibility genes.

Loman N, Johannsson O, Bendahl PO, Borg A, Fernö M, Olsson H. Loman N, et al. Among authors: bendahl po. Cancer. 1998 Jul 15;83(2):310-9. Cancer. 1998. PMID: 9669814

6

S-phase fraction and urokinase plasminogen activator are better markers for distant recurrences than Nottingham Prognostic Index and histologic grade in a prospective study of premenopausal lymph node-negative breast cancer.

Malmström P, Bendahl PO, Boiesen P, Brünner N, Idvall I, Fernö M; South Sweden Breast Cancer Group. Malmström P, et al. Among authors: bendahl po. J Clin Oncol. 2001 Apr 1;19(7):2010-9. doi: 10.1200/JCO.2001.19.7.2010. J Clin Oncol. 2001. PMID: 11283134

7

Urokinase plasminogen activator and its inhibitor, PAI-1, in association with progression-free survival in early stage endometrial cancer.

Fredstorp-Lidebring M, Bendahl PO, Brünner N, Casslén B, Högberg T, Långström-Einarsson E, Willén R, Fernö M. Fredstorp-Lidebring M, et al. Among authors: bendahl po. Eur J Cancer. 2001 Dec;37(18):2339-48. doi: 10.1016/s0959-8049(01)00306-9. Eur J Cancer. 2001. PMID: 11720826

8

High tumor tissue concentration of plasminogen activator inhibitor 2 (PAI-2) is an independent marker for shorter progression-free survival in patients with early stage endometrial cancer.

Nordengren J, Fredstorp Lidebring M, Bendahl PO, Brünner N, Fernö M, Högberg T, Stephens RW, Willén R, Casslén B. Nordengren J, et al. Among authors: bendahl po. Int J Cancer. 2002 Jan 20;97(3):379-85. doi: 10.1002/ijc.1611. Int J Cancer. 2002. PMID: 11774293

9

Pooled analysis of prognostic impact of urokinase-type plasminogen activator and its inhibitor PAI-1 in 8377 breast cancer patients.

Look MP, van Putten WL, Duffy MJ, Harbeck N, Christensen IJ, Thomssen C, Kates R, Spyratos F, Fernö M, Eppenberger-Castori S, Sweep CG, Ulm K, Peyrat JP, Martin PM, Magdelenat H, Brünner N, Duggan C, Lisboa BW, Bendahl PO, Quillien V, Daver A, Ricolleau G, Meijer-van Gelder ME, Manders P, Fiets WE, Blankenstein MA, Broët P, Romain S, Daxenbichler G, Windbichler G, Cufer T, Borstnar S, Kueng W, Beex LV, Klijn JG, O'Higgins N, Eppenberger U, Jänicke F, Schmitt M, Foekens JA. Look MP, et al. Among authors: bendahl po. J Natl Cancer Inst. 2002 Jan 16;94(2):116-28. doi: 10.1093/jnci/94.2.116. J Natl Cancer Inst. 2002. PMID: 11792750 Free article.

10

Loss of Wnt-5a protein is associated with early relapse in invasive ductal breast carcinomas.

Jönsson M, Dejmek J, Bendahl PO, Andersson T. Jönsson M, et al. Among authors: bendahl po. Cancer Res. 2002 Jan 15;62(2):409-16. Cancer Res. 2002. PMID: 11809689

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

199 results

Search Page

Filters